VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Est. Return
12.28%
1 Year Est. Return
-12.28%
AUM
$1.9B
AUM Growth
+$499M
(+36%)
Holding
85
Top Buys
| 1 | +$127M | |
| 2 | +$46.3M | |
| 3 | +$44.1M | |
| 4 |
Amicus Therapeutics
FOLD
|
+$43.7M |
| 5 |
Exact Sciences
EXAS
|
+$37.2M |
Top Sells
| 1 | +$82M | |
| 2 | +$23.8M | |
| 3 | +$18.1M | |
| 4 |
Liquidia Corp
LQDA
|
+$18.1M |
| 5 |
Establishment Labs
ESTA
|
+$17.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$4.73B
| $181M | 9.53% |
2,750,000
+362,280
|
|
||
2
Jazz Pharmaceuticals
JAZZ
$8.42B
| $127M | 6.7% |
+1,200,000
|
|
||
3
Cytokinetics
CYTK
$6.94B
| $98.3M | 5.18% |
2,975,000
+384,469
|
|
||
4
Nuvalent
NUVL
$6.74B
| $82M | 4.32% |
1,075,000
|
|
||
5
Vera Therapeutics
VERA
$1.88B
| $73M | 3.85% |
3,100,000
+600,000
|
|
||
|
6
Amicus Therapeutics
FOLD
$2.69B
| $68.2M | 3.59% |
11,900,000
+7,625,000
|
|
||
7
Xenon Pharmaceuticals
XENE
$3.16B
| $62.6M | 3.3% |
2,000,000
+700,000
|
|
||
8
Dianthus Therapeutics
DNTH
$1.3B
| $59.6M | 3.14% |
3,200,000
+1,499,931
|
|
||
9
Scholar Rock
SRRK
$2.84B
| $53.1M | 2.8% |
1,500,000
+200,000
|
|
||
10
KalVista Pharmaceuticals
KALV
$564M
| $52.9M | 2.78% |
4,675,000
-76,292
|
|
||
11
GE HealthCare
GEHC
$35.5B
| $51.8M | 2.73% |
700,000
+495,870
|
|
||
12
uniQure
QURE
$3.78B
| $51.6M | 2.72% |
3,700,000
-1,092,572
|
|
||
|
BCAX
13
Bicara Therapeutics
BCAX
$936M
| $46.5M | 2.45% |
5,000,000
+2,231,025
|
|
||
14
Alcon
ALC
$37.7B
| $46.3M | 2.44% |
+525,000
|
|
||
15
Revolution Medicines
RVMD
$10.3B
| $44.1M | 2.32% |
+1,200,000
|
|
||
16
Crinetics Pharmaceuticals
CRNX
$3.87B
| $43.1M | 2.27% |
1,500,000
|
|
||
|
17
Exact Sciences
EXAS
$12.3B
| $37.2M | 1.96% |
+700,000
|
|
||
18
Celldex Therapeutics
CLDX
$1.76B
| $35.6M | 1.88% |
1,750,000
+1,551,354
|
|
||
19
Ascendis Pharma
ASND
$12.2B
| $34.5M | 1.82% |
200,000
+49,858
|
|
||
20
Immatics
IMTX
$1.24B
| $33.6M | 1.77% |
6,250,000
-942,700
|
|
||
21
Geron
GERN
$785M
| $33.5M | 1.77% |
23,775,000
+1,769,660
|
|
||
22
Globus Medical
GMED
$8.42B
| $29.5M | 1.55% |
500,000
+300,000
|
|
||
23
BioMarin Pharmaceuticals
BMRN
$10.5B
| $27.5M | 1.45% |
+500,000
|
|
||
24
MoonLake Immunotherapeutics
MLTX
$605M
| $26M | 1.37% |
550,000
+350,000
|
|
||
25
Tyra Biosciences
TYRA
$761M
| $25.4M | 1.34% |
2,655,000
-224,829
|
|